Opendata, web and dolomites


Indentification and optimisation of novel anti-infective agents using multiple hit-identification strategies

Total Cost €


EC-Contrib. €






 NovAnI project word cloud

Explore the words cloud of the NovAnI project. It provides you a very rough idea of what is the project "NovAnI" about.

chemistry    incidence    unconventional    synthetic    thereby    organic    exhaustion    coupling    cutting    expertise    antimalarial    provides    tuberculosis    small    erc    mycobacterium    antituberculotic    health    strategies    return    importers    action    flexibility    aureus    excellent    urgently    wall    position    first    place    edge    combination    un    energy    transporters    repair    few    interdisciplinary    causative    polymerase    difficult    explored    positive    diseases    hit    threat    collaborations    biochemists    employing    rapid    goals    methicillin    pathogens    infectives    fact    anti    builds    synergistic    investment    protein    selectivity    clamp    million    given    platform    dxs    molecule    cell    sliding    negative    emergence    identification    vitamin    der    dnan    dna    mrsa    serious    drug    biosynthetic    resistance    bacteria    deaths    antibacterial    biochemical    circumventing    staphylococcus    peculiar    give    mode    inhibitors    agent    infective    absent    resistant    infections    crossing    pharmacologists    medicinal    potentially    humans    drugs    crystallographers    agents    gram    scaffolds    me    context   

Project "NovAnI" data sheet

The following table provides information about the project.


Organization address
postcode: 38124

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 1˙499˙367 €
 EC max contribution 1˙499˙367 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-STG
 Funding Scheme ERC-STG
 Starting year 2018
 Duration (year-month-day) from 2018-02-01   to  2023-01-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

Given the rapid emergence of anti-infective resistance, drugs with a novel mode of action are urgently needed. Because of an exhaustion of existing strategies, a low return on investment and the fact that anti-infectives are difficult to develop (e.g., crossing the peculiar cell wall of Mycobacterium tuberculosis), promising un(der)explored targets and unconventional hit-identification strategies are needed.

I have selected three anti-infective targets based on their biochemical context for which few or no small-molecule inhibitors are known:

1) The antimalarial and antituberculotic drug target DXS is part of a unique biosynthetic pathway for pathogens that is absent in humans, thereby circumventing selectivity issues. Both diseases are a serious health threat with around 1.9 million deaths per year. 2) Energy-coupling factor transporters are essential vitamin importers for pathogens such as Staphylococcus aureus, the causative agent of methicillin-resistant Staphylococcus aureus (MRSA) infections. 3) The DNA polymerase sliding clamp DnaN has polymerase and DNA repair activities and is an excellent drug target for the development of antibacterial agents against Gram-negative and –positive bacteria given the low incidence of resistance development.

I will address these targets, employing a unique combination of potentially synergistic hit-identification strategies that take into account protein flexibility, provide access to novel scaffolds and give me a cutting edge for the development of novel anti-infectives.

This ERC proposal builds on my experience with the first two targets and provides an excellent platform for the new target DnaN. My expertise in synthetic organic and medicinal chemistry and established hit-identification strategies together with my collaborations with protein crystallographers, biochemists and pharmacologists place me in an excellent position for not only achieving the goals of this interdisciplinary proposal but also going beyond it.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NOVANI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NOVANI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

SuperH (2019)

Discovery and Characterization of Hydrogen-Based High-Temperature Superconductors

Read More  

InsideChromatin (2019)

Towards Realistic Modelling of Nucleosome Organization Inside Functional Chromatin Domains

Read More  


The Enemy of the Good: Towards a Theory of Moral Progress

Read More